1Duan L, Gan H, Golan DE, et al. Critical role of mitochondrial damage in determining outcome of macrophage infection with Mycobacterium tuberculosis.J Immunol,2002,169:5181-5187.
2Mustafa T, Bjune TG, Jonsson R,et al. Increased expression of fas ligand in human tuberculosis and leprosy lesions: a potential novel mechanism of immune evasion in mycobacterial infection.Scand J Immunol,2001,54:630-639.
3Manfredi AA,Heltai S,Rovere P,et al. Mycobacterium tuberculosis exploits the CD95/CD95 ligand system of γδT cells to cause apoptosis.Eur J Immunol,1998,28:1798-1806.
4Oddo M,Renno T,Attinger A,et al.Fas lingand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J Immunol,1998,160:5448-5454.
5Perskvist N, Long M, Stendahl O,et al. Mycobacterium tuberculosis promotes apoptosis in human neutrophils by activating caspase-3 and altering expression of Bax/Bcl-xL via an oxygen-dependent pathway.J Immunol,2002,168:6358-6365.
6Mogga SJ, Mustafa T, Sviland L,et al. Increased Bcl-2 and reduced Bax expression in infected macrophages in slowly progressive primary murine Mycobacterium tuberculosis infection.Scand J Immunol,2002,56:383-391.
7Sly LM,Wilson SMH,Reiner NE,et al.Survival of Mycobacterium tuberculosis in host macrophages involves resistance to apoptosis dependent upon induction of antiapoptotic Bcl-2 family member Mcl-1.J Immunol,2003,170: 430-437.
8Thoma-Uszynski S,Stenger S,Modlin RL,et al.CTL-mediated killing of intracellular Mycobacterium tuberculosis is independent of target cell nuclear apoptosis.J Immunol, 2000,165:5773-5779.
9Balcewicz-Sablinska MK, Keane J,Kornfeld H,et al.Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2,resulting in inactivation of TNF-α.J Immunol,1998,161:2636-2641.
10Keane J,Shurtleff B,Kornfeld H.TNF-dependent BALB/c murine macrophage apoptosis following Mycobacterium tuberculosis infection inhibits bacillary growth in an IFN-gamma independent manner.Tuberculosis,2002,82:55-61.
4Lazarevic V, Nolt D, Flynn JL. Long-term control of Mycobacterium tuberculosis infection is mediated by dynamic immune responses. J Immunol, 2005,175 : 1107-1117.
5de la Barrera S, Aleman M, Musella R, et al. IL-10 down-regulates costimulatory molecules on Mycobacterium tuberculosis-pulsed macrophages and impairs the lytie activity of CD4 and CD8 CTL in tuberculosis patients. Clin Exp Immunol, 2004,138 : 128-138.
6Tully G, Kortsik C, Hohn H, et al. Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection. J Immunol, 2005,174 : 2174-2184.
7Ewer K, Millington KA, Deeks JJ, et al. Dynamic antigenspecific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med, 2006,174 : 831-839.
8Veenstra H, Baumann R, Carroll NM, et al. Changes in leucocyte and lymphocyte subsets during tuberculosis treatment;prominence of CD3dim CD56+ natural killer T cells in fast treatment responders. Clin Exp Immunol, 2006, 145 : 252-260.
9Rojas RE, Balaji KN, Subramanian A, et al. Regulation of human CD4 ( + ) alphabeta T-cell-receptor-positive ( TCR (+)) and gammadeha TCR (+) T-cell responses to Mycobacterium tuberculosis by interleukin-10 and transforming growth factor beta. Infect Immun, 1999, 67: 6461-6472.
10Sieling PA, Ochoa MT, Jullien D, et al. Evidence for human CD4^+ T cells in the CDl-restricted repertoire: derivation of mycobacteria-reactive T cells from leprosy lesions. J Immunol, 2000,164 : 4790-4796.
